Clinical trials

  • IVOSIDENIB for Acute myeloid leukemia (AML) | IDH1-mutated AML | IDH2-mutated AML
  • NAPORAFENIB for Melanoma (BRAFV600 or NRAS mutant)
  • BFB759 for Atopic dermatitis
  • SIPONIMOD FUMARIC ACID for Multiple sclerosis
  • IANALUMAB for Diffuse cutaneous systemic sclerosis (dcSSc)
  • METHYLPREDNISOLONE for Kidney transplant
  • ZANIDATAMAB for Endometrial cancer | Colorectal cancer | Head and neck cancer | Sarcoma | Non-small cell lung cancer
  • apixaban for Venous malformation
  • Gadoteric acid for Breast cancer
  • ANHYDROUS LIDOCAINE HYDROCHLORIDE for Post-dural puncture syndrome
  • DAPAGLIFLOZIN for Decompensated liver cirrhosis | Liver cirrhosis
  • Lutetium (177Lu) oxodotreotide for Small intestine neuroendocrine tumour | Stage III (locoregionally restricted) small intestine neuroendocrine tumour